MR appearance of extravasated gadolinium contrast medium.
DA Carrier, JJ Ford, LA Hayman - American journal of …, 1993 - Am Soc Neuroradiology
This case illustrates that a large zone of signal void can be produced on short relaxation
time MR images when gadopentate dimeglumine is injected through an infiltrated …
time MR images when gadopentate dimeglumine is injected through an infiltrated …
Histologic abnormalities associated with gadolinium enhancement on MR in the initial hours of experimental cerebral infarction.
VP Mathews, LH Monsein… - American journal of …, 1994 - Am Soc Neuroradiology
PURPOSE To determine the histologic changes associated with gadopentetate
dimeglumine enhancement on MR images in acute focal cerebral ischemia. METHODS In …
dimeglumine enhancement on MR images in acute focal cerebral ischemia. METHODS In …
A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system
J Valk, PR Algra, CJ Hazenberg, WBM Slooff… - Neuroradiology, 1993 - Springer
Seventy-nine patients with known or suspected central nervous system lesions were studied
with MRI in a phase III double-blind study. Forty were given gadopentetate dimeglumine (Gd …
with MRI in a phase III double-blind study. Forty were given gadopentetate dimeglumine (Gd …
Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions
EJ Russell, TF Schaible, W Dillon… - American journal …, 1989 - Am Soc Neuroradiology
A multicenter double-blind randomized study was designed to evaluate and compare the
safety and diagnostic efficacy of gadopentetate dimeglumine (Gd-DTPA)(0.1 mmol/kg) …
safety and diagnostic efficacy of gadopentetate dimeglumine (Gd-DTPA)(0.1 mmol/kg) …
Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA
D Balériaux, C Matos, D De Greef - Neuroradiology, 1993 - Springer
The tolerance and diagnostic efficacy of a new nonionic, intravenous MRI contrast medium,
gadodiamide injection (Omniscan®) are reported and compared with those of gadolinium …
gadodiamide injection (Omniscan®) are reported and compared with those of gadolinium …
Gadopentetate dimeglumine-enhanced MR of the brain: clinical utility and safety in patients younger than two years of age.
OP Eldevik, JA Brunberg - American journal of …, 1994 - Am Soc Neuroradiology
PURPOSE To evaluate the clinical utility and safety of gadopentetate dimeglumine as a
contrast agent for MR of the brain in patients younger than 2 years of age. METHODS In 125 …
contrast agent for MR of the brain in patients younger than 2 years of age. METHODS In 125 …
Early cerebral infarction: gadopentetate dimeglumine enhancement.
AD Elster, DM Moody - Radiology, 1990 - pubs.rsna.org
Gadopentetate dimeglumine was administered prospectively to 50 patients who presented
for magnetic resonance (MR) imaging within 2 weeks after a cortical cerebral infarction …
for magnetic resonance (MR) imaging within 2 weeks after a cortical cerebral infarction …
The effect of intravenous gadolinium on the magnetic resonance appearance of cerebrospinal fluid
RK KNUTZON, VC POIRIER… - Investigative …, 1991 - journals.lww.com
The authors determined whether a sufficient amount of intravenously administered
gadolinium enters the cerebrospinal fluid (CSF) to visibly shorten the T1 relaxation time …
gadolinium enters the cerebrospinal fluid (CSF) to visibly shorten the T1 relaxation time …
Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients
DH Carr, J Brown, GM Bydder… - American Journal of …, 1984 - Am Roentgen Ray Soc
Magnetic resonance imaging (MRI) was performed in 20 patients before and after
intravenous administration of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) in …
intravenous administration of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) in …
Gadolinium—DTPA in magnetic resonance imaging of the brain
J Valk, RGM De Slegte, FC Crezee, GJ Hazenberg… - Neurosurgical …, 1987 - Springer
This report concerns a clinical trial with Gd-DTPA as an intravenous contrast medium for MRI
in patients with neurological disorders. 50 patients (30 female, 20 male) were examined …
in patients with neurological disorders. 50 patients (30 female, 20 male) were examined …
